CVS Health Corporation Company Profile (NYSE:CVS)

Analyst Ratings

Consensus Ratings for CVS Health Corporation (NYSE:CVS) (?)
Ratings Breakdown: 4 Hold Rating(s), 17 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $113.74 (22.67% upside)

Analysts' Ratings History for CVS Health Corporation (NYSE:CVS)
Show:
DateFirmActionRatingPrice TargetActions
7/4/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2016MizuhoReiterated RatingBuy$117.00 -> $108.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2016Deutsche Bank AGBoost Price TargetHold$99.00 -> $105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2016Morgan StanleyDowngradeOverweight -> Equal Weight$111.00 -> $104.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/10/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2016Credit Suisse Group AGReiterated RatingBuy$115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2016FBR & CoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2016Citigroup Inc.Boost Price TargetNeutral$105.00 -> $115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016MacquarieReiterated RatingOutperform$115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Royal Bank Of CanadaReiterated RatingOutperform$110.00 -> $115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2016Barclays PLCBoost Price TargetOverweight$110.00 -> $115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016GuggenheimLower Price TargetBuy$120.00 -> $115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016Goldman Sachs Group Inc.Boost Price TargetNeutral$106.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Atlantic SecuritiesInitiated CoverageOverweight$114.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2016Robert W. BairdInitiated CoverageOutperform$108.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2015Oppenheimer Holdings Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2015S&P Equity ResearchUpgradeStrong-Buy$121.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015Raymond James Financial Inc.Boost Price TargetOutperform$105.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015BMO Capital MarketsBoost Price TargetOutperform$103.00 -> $113.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015JPMorgan Chase & Co.Lower Price TargetOverweight$128.00 -> $123.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015Evercore ISILower Price TargetBuy$111.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015Cowen and CompanyLower Price Target$118.00 -> $113.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/10/2015ArgusBoost Price TargetBuy$114.00 -> $118.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2015Cantor FitzgeraldReiterated RatingHold$83.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2015Noble FinancialReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/21/2015StephensInitiated CoverageOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/2/2015Bank of America Corp.Set Price TargetBuy$94.00 -> $104.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014SunTrust Banks Inc.UpgradeNeutral -> Buy$92.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for CVS Health Corporation (NYSE:CVS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016Q216$1.30$44.28 billionN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2016Q116$1.16$1.18$43.01 billion$43.20 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2016Q415$1.53$1.53$41.12 billion$41.15 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2015Q315$1.29$1.28$37.81 billion$38.50 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215$1.20$1.22$37.18 billion$37.20 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2015Q115$1.08$1.14$35.93 billion$36.30 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2015Q414$1.20$1.21$36.06 billion$37.06 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q314$1.13$1.15$34.74 billion$35.00 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214$1.10$1.13$33.47 billion$34.60 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2014Q114$1.05$1.02$32.31 billion$32.70 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2014Q413$1.11$1.12$32.67 million$32.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313$1.02$1.05$31.53 billion$32.00 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2013Q2 2013$0.96$0.97$31.13 billion$31.25 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2013Q113$0.79$0.83$30.36 billion$30.76 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2013Q4 2012$1.10$1.14$31.13 billion$31.40 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2012Q312$0.84$0.85$30.09 billion$30.23 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012$0.80$0.81ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2012$0.63$0.65ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2011$0.68$0.70ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2011$0.65$0.65ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2011$0.55$0.57ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2011$0.79$0.80ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for CVS Health Corporation (NYSE:CVS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$1.15$1.19$1.17
Q2 20166$1.30$1.36$1.31
Q3 20166$1.52$1.61$1.55
Q4 20166$1.74$1.86$1.80
Q1 20173$1.30$1.33$1.32
Q2 20173$1.49$1.61$1.53
Q3 20173$1.66$1.78$1.73
Q4 20173$1.89$2.02$1.96
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for CVS Health Corporation (NYSE:CVS)
Annual Dividend:$1.70
Dividend Yield:1.83%
Payout Ratio:36.88% (Based on Trailing 12 Months of Earnings)
29.21% (Based on Current Year Consensus EPS Estimate)
25.88% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:29.10% (3 Year Average)

Dividend History for CVS Health Corporation (NYSE:CVS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
7/6/2016quarterly$0.431.78%7/19/20167/21/20168/1/2016Tweet This Announcement  Share This Announcement on StockTwits
3/2/2016quarterly$0.431.71%4/20/20164/22/20165/2/2016Tweet This Announcement  Share This Announcement on StockTwits
12/16/2015quarterly$0.431.79%1/20/20161/22/20162/2/2016Tweet This Announcement  Share This Announcement on StockTwits
10/1/2015quarterly$0.351.41%10/20/201510/22/201511/2/2015Tweet This Announcement  Share This Announcement on StockTwits
7/8/2015quarterly$0.351.32%7/21/20157/23/20158/3/2015Tweet This Announcement  Share This Announcement on StockTwits
3/4/2015quarterly$0.351.35%4/22/20154/24/20155/4/2015Tweet This Announcement  Share This Announcement on StockTwits
12/17/2014quarterly$0.351.49%1/20/20151/22/20152/2/2015Tweet This Announcement  Share This Announcement on StockTwits
9/24/2014quarterly$0.281.38%10/21/201410/23/201411/3/2014Tweet This Announcement  Share This Announcement on StockTwits
7/10/2014quarterly$0.281.43%7/17/20147/21/20148/1/2014Tweet This Announcement  Share This Announcement on StockTwits
3/6/2014quarterly$0.281.5%4/17/20144/22/20145/2/2014Tweet This Announcement  Share This Announcement on StockTwits
12/18/2013quarterly$0.281.57%1/21/20141/23/20142/3/2014Tweet This Announcement  Share This Announcement on StockTwits
9/25/2013quarterly$0.231.55%10/17/201310/21/201311/1/2013Tweet This Announcement  Share This Announcement on StockTwits
7/10/2013quarterly$0.231.48%7/18/20137/22/20138/2/2013Tweet This Announcement  Share This Announcement on StockTwits
3/6/2013quarterly$0.231.73%4/19/20134/23/20135/3/2013Tweet This Announcement  Share This Announcement on StockTwits
12/13/2012quarterly$0.231.83%1/22/20131/24/20132/4/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for CVS Health Corporation (NYSE:CVS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/5/2016Larry J MerloCEOSell38,247$105.00$4,015,935.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2016Troyen A BrennanEVPSell7,517$105.00$789,285.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2016Stephen J GoldEVPSell21,922$105.00$2,301,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2016Larry J MerloCEOSell38,247$100.00$3,824,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2016Jonathan C. RobertsEVPSell23,355$92.86$2,168,745.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/1/2016Larry J. MerloCEOSell46,393$96.14$4,460,223.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2016Larry J. MerloCEOSell46,393$95.00$4,407,335.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/27/2015Troyen A. BrennanEVPSell23,603$105.00$2,478,315.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/20/2015Eva C BorattoSVPSell22,107$110.34$2,439,286.38View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015Lisa BisacciaEVPSell49,908$110.00$5,489,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015C David Brown IIDirectorSell10,000$102.57$1,025,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2015C David Brown IIDirectorSell15,000$100.27$1,504,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2015Andrew SussmanEVPSell17,638$102.38$1,805,778.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2015Troyen A BrennanEVPSell33,384$102.48$3,421,192.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Troyen A BrennanEVPSell33,274$104.94$3,491,773.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/20/2015C David Brown IIDirectorSell25,000$104.30$2,607,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2015Jonathan C RobertsEVPSell86,487$95.31$8,243,075.97View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Larry J MerloCEOSell144,144$94.30$13,592,779.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Andrew SussmanSVPSell4,220$95.67$403,727.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Per Gh LofbergEVPSell347,343$95.28$33,094,841.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2014Helena FoulkesEVPSell46,325$88.06$4,079,379.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/27/2014Lisa BisacciaSVPSell33,507$85.00$2,848,095.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Andrew SussmanSVPSell9,020$79.45$716,639.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/6/2014J. David JoynerEVPSell123,516$76.10$9,399,567.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/21/2014Eva C BorattoSVPSell22,107$76.77$1,697,154.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014David M DentonCFOSell74,989$75.88$5,690,165.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2014Eva BorattoSVPSell17,108$74.51$1,274,717.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2014Troyen BrennanEVPSell18,867$74.33$1,402,384.11View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/3/2014David DentonCFOSell14,113$70.50$994,966.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/3/2014Per Gh LofbergEVPSell790,888$70.54$55,789,239.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014Jonathan RobertsEVPSell162,192$70.61$11,452,377.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014Larry MerloCEOSell228,875$70.76$16,195,195.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2013Lisa BisacciaSVPSell12,057$68.00$819,876.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2013Troyen BrennanEVPSell35,387$65.61$2,321,741.07View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/18/2013Eva C BorattoSVPSell11,053$60.50$668,706.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/11/2013Eva BorattoSVPSell11,053$59.50$657,653.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2013Helena FoulkesEVPSell53,546$60.00$3,212,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013Helena FoulkesEVPSell47,568$58.65$2,789,863.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2013Andrew SussmanSVPSell9,020$58.36$526,407.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/4/2012Andrew SussmanSVPSell9,020$49.00$441,980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2012Thomas M MoriartyEVPBuy6,164$48.67$300,001.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2012David M DentonCFOSell11,526$47.00$541,722.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2012Jean Pierre MillonDirectorSell33,726$45.73$1,542,289.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for CVS Health Corporation (NYSE:CVS)
DateHeadline
07/29/16 08:53 PMCVS Health : Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations in Texas
07/29/16 03:36 PMBright Rock Capital Management buys $6977379 stake in CVS Health Corp (CVS) - Trade Calls
07/29/16 12:34 PMCVS Health To Boost Access To FDA-approved Nasal Naloxone For Patients Without Insurance -
07/29/16 09:38 AMCVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations in Texas - [at noodls] - WOONSOCKET, R.I., July 25, 2016/PRNewswire/ -- CVS Health (NYSE: CVS) announced today that the opioid overdose-reversal medication naloxone is now available without a prescription at all CVS Pharmacy locations ...
07/29/16 09:11 AMCVS Health to Increase Access to FDA-approved Nasal Naloxone for Patients without Insurance through Improved Affordability of NARCAN® Nasal Spray at CVS Pharmacy Locations - [PR Newswire] - WOONSOCKET, R.I., July 29, 2016 /PRNewswire/ -- CVS Health (NYSE: CVS) and Adapt Pharma ( www.AdaptPharma.com ) today announced a new partnership that will make the opioid overdose-reversing drug NARCAN® ...
07/29/16 07:19 AMCVS Health Corp (NYSE:CVS) is Under The Radar Brokerage Ratings - The Voice Registrar
07/29/16 07:19 AMFocused Investors Lowers stake in CVS Health Corp (CVS) – Trade ... - Trade Calls
07/29/16 07:06 AMIs CVS Health Getting Healthy? -
07/28/16 04:31 PMCVS Health Corp: Earnings Preview - Motley Fool
07/28/16 07:21 AMCVS Health Corp: Earnings Preview -
07/27/16 09:11 PMHC Stocks Growth: CVS Health Corp (NYSE:CVS), EXACT Sciences Corporation (NASDAQ:EXAS) - share market updates (press release)
07/27/16 09:11 PMAnalysts Observing Trading Stocks: CVS Health Corporation (NYSE:CVS) , Thermo Fisher Scientific Inc (NYSE:TMO) - Street Updates
07/27/16 09:11 PMCVS Health Corporation (NYSE:CVS) Stock Declines, Analysts: Buy Rating - Review Fortune
07/27/16 09:11 PMCVS Health (CVS) Q2 Earnings: What's in the Cards? - Nasdaq
07/27/16 09:11 PMEye Catching Stock: CVS Health Corporation (NYSE:CVS) - News Oracle
07/27/16 05:43 PMCVS Health (CVS) Q2 Earnings: What's in the Cards? -
07/27/16 03:35 PMFirst Circuit Asked to Revive CVS Vitamin E Class Action Lawsuit
07/26/16 03:29 PMCVS Health to make opioid overdose-reversal drug available without prescription in Texas
07/26/16 11:42 AMCVS Health Corporation (CVS) Falls 2.6% for July 25
07/26/16 08:47 AMHow one investor is playing CVS Caremark -
07/26/16 07:25 AMCVS Health Corp. breached its 50 day moving average in a Bearish Manner : CVS-US : July 26, 2016 -
07/25/16 08:16 PMCVS Health Corporation (CVS) Falls 2.6% for July 25 - Equities.com
07/25/16 02:45 PMCVS Health Corporation (CVS) Shares are Down -0.56% - Trade Calls
07/25/16 10:10 AMCVS Health Says Overdose-Reversal Drug Is Now Available Without A Prescription In Texas -
07/25/16 08:13 AMHC Stocks Highlights: Baxter International Inc (NYSE:BAX) CVS Health Corp (NYSE:CVS) - share market updates (press release)
07/23/16 07:11 AMFriday Session Wrap-up for CVS Health Corporation (NYSE:CVS) - Engelwood Daily
07/22/16 02:55 PMCarlton Hofferkamp Jenks Wealth Management buys $1254598 stake in CVS Health Corp (CVS) - Trade Calls
07/22/16 02:55 PMAre Analysts Still Saying "Buy" this Stock: CVS Health Corporation (NYSE:CVS) - TGP
07/22/16 02:55 PMHC Stocks Zone: Bristol-Myers Squibb Co (NYSE:BMY), CVS Health Corp (NYSE:CVS) - share market updates (press release)
07/22/16 02:55 PMEarnings Estimates Analysis: CVS Health Corporation (NYSE:CVS) - News Oracle
07/22/16 02:55 PMCVS Health: Stock Valuations Are Compelling - Seeking Alpha
07/22/16 02:55 PMCVS Health Corporation To Hold Second Quarter 2016 Conference Call - PR Newswire (press release)
07/22/16 11:00 AMCVS Health Corporation To Hold Second Quarter 2016 Conference Call - [PR Newswire] - WOONSOCKET, R.I., July 22, 2016 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) will be holding a conference call on Tuesday, August 2, 2016, at 8:30 a.m. (EDT) with analysts and investors to discuss ...
07/22/16 08:50 AMHealth Care Plans' Stocks Under Review -- CVS Health, Express Scripts Holding, UnitedHealth Group, and Centene
07/21/16 09:01 PMCVS Health Corporation Common S (CVS) Position Increased by Martin Investment Management, LLC Last Quarter - Finance Daily
07/21/16 09:01 PMAnalyst Opinion of: CVS Health Corporation (NYSE:CVS) - News Oracle
07/21/16 09:01 PMStock Session in the Rear-View for CVS Health Corporation (NYSE:CVS) - TGP
07/21/16 09:01 PMBetter Buy: CVS Health Corp vs. Express Scripts - Madison.com
07/21/16 04:28 AMCVS Health Corporation (NYSE:CVS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/21/16 04:28 AMAnalysts Holding Strong to their Buy Rating on: CVS Health Corporation (NYSE:CVS) - TGP
07/21/16 04:28 AMHC Stocks Outlines: CVS Health Corp (NYSE:CVS), EXACT Sciences Corporation (NASDAQ:EXAS) - share market updates (press release)
07/21/16 04:28 AMBetter Buy: CVS Health Corp vs. Express Scripts - Motley Fool
07/21/16 04:28 AMStrategy To YieldBoost CVS Health Corporation From 1.8% To 3.9% Using Options - Nasdaq
07/20/16 04:40 PMStrategy To YieldBoost CVS Health Corporation From 1.8% To 3.9% Using Options
07/20/16 03:44 PMUnitedHealth's Obamacare Shun, Recent Deals, Make It Attractive for the Future -
07/20/16 03:08 PMRecent Dip in CVS Shares Presents Buying Opportunity, Analysts Say -
07/19/16 08:50 PMShares Positive Over the Past Month: CVS Health Corporation (NYSE:CVS) - TGP
07/19/16 08:50 PMStock Strength in Focus for CVS Health Corporation (NYSE:CVS) - Press Telegraph
07/19/16 08:50 PMStock Check-In at the Close: CVS Health Corporation (NYSE:CVS) - TGP
07/19/16 09:38 AMStock Positive on the Year: CVS Health Corporation (NYSE:CVS) - TGP

Social

About CVS Health Corporation

CVS Health Corporation logoCVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, photo finishing, seasonal merchandise and greeting cards through the Company's retail stores, online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company, through its wholly owned subsidiary, Omnicare, Inc., provides pharmacy services to long term care facilities.

Industry, Sector and Symbol:
  • Sector: Retail/Wholesale
  • Industry: Health Care Plans
  • Sub-Industry: Drug Retail
  • Exchange: NYSE
  • Symbol: CVS
  • CUSIP: 12665010
Key Metrics:
  • Previous Close: $92.72
  • 50 Day Moving Average: $95.28
  • 200 Day Moving Average: $98.22
  • P/E Ratio: 20.15
  • P/E Growth: 1.07
  • Market Cap: $99.58B
  • Beta: 0.85
  • Current Year EPS Consensus Estimate: $5.82 EPS
  • Next Year EPS Consensus Estimate: $6.57 EPS
Additional Links:
CVS Health Corporation (NYSE:CVS) Chart for Saturday, July, 30, 2016